Legionnaires' discovery prompts GlaxoSmithKline to idle NC plant

After detecting the bacteria for Legionnaires' disease in a cooling tower, GlaxoSmithKline ($GSK) temporarily closed a manufacturing site in North Carolina. GSK sent employees home while it cleans the tower and investigates. The discovery comes as an outbreak of the infection has resulted in a dozen deaths in New York. More from FiercePharma

Suggested Articles

The Pharma Lions shortlist for 2019 lives up to its name with just 31 entries making the cut. But it's still good news for the 12 drugmaker finalists.

Pharma companies filed suit Friday to block the new HHS rule that requires drugmakers to put list prices in TV ads.

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.